Admirus Consulting is a boutique Medical and Regulatory consultancy bringing over 50 years of experience in developing, registering, launching, and commercialising medicines across the globe.
We have considerable first-hand experience in the majority of major global markets, including Europe, USA, Japan, China, India, Australia, New Zealand, and Asia-Pacific.
Whilst our expertise is broad, we specialise in working with clients who want to develop drugs in Asia-Pacific, bring globally developed products to the Asia-Pacific region or those wanting medical or regulatory input to maximise their business potential.
ABOUT US
ADMIRUS Consulting is a leading provider of strategic regulatory and medical consulting services in the fields of Biotechnology and Healthcare. We are located in Sydney, Australia, and we provide a diverse range of services and consultancy to healthcare clients globally.
At ADMIRUS, we offer a strategic collaboration that positions us as the ideal partner for clients wishing to develop, register and prepare for launch of drugs in the Asia-Pacific region or those wishing to bring globally-approved products to Asia-Pacific and need to bridge clinical and regulatory requirements.
Whether you're establishing a presence in Asia-Pacific or already have a foothold, our pragmatic and innovative approach is designed to accelerate and drive your business forward.
OUR TEAM
Michael has a deep understanding of drug development, having been the global regulatory leader for numerous early and late-stage development compounds. He has led multiple meetings with European Health Authorities (including the EMA) and US FDA and has a successful track record in gaining regulatory approvals for new chemical entities in both jurisdictions.
Michael is a pharmacist with additional post-graduate qualifications in Biopharmacy and Regulatory Affairs (TOPRA). He grew up in New Zealand and spent 13 years in the UK (Pharmascience, Shire Pharmaceuticals), 4 years in Switzerland (Actelion), 2 years in China (Actelion) and 15 years in Australia (Actelion, Janssen), all as a regulatory affairs specialist.
Andrea obtained her Doctor of Medicine (MD) qualification in Switzerland and has more than 20 years’ experience in clinical development and medical marketing within the pharmaceutical industry (Roche, Actelion, Janssen).
Her experience includes global clinical development, and she has held senior leadership positions at Actelion/Janssen in both China and ANZ.
Prior to establishing ADMIRUS, she held positions in global R&D (Switzerland) as clinical trial physician (phase I-IV) and in medical affairs in positions of increasing responsibility.